Second Annual Conference The Sixth Vital Sign: What Every Oncologist Should Know About Molecular Oncology: Applications to Patient Care

Scottsdale, AZ
Second Annual Conference
The Sixth Vital Sign: What Every Oncologist Should Know About Molecular Oncology—Applications to Patient Care

Schedule of Presentations:

Thursday, February 11, 2010
12:30:00 Registration and Refreshments
13:00:00 Welcome and Introductions Daniel Von Hoff
13:10:00 Presession Survey
13:20:00 Plenary Lecture: The Future of Personalized Therapy Jeffrey M. Trent
13:25:00 Targeted Therapy Based on Molecular Profiling Daniel Von Hoff
14:00:00 Tumor Genomics Carolyn C. Compton
14:30:00 c-Met in Breast Cancer
15:00:00 State of the Art for Advanced Breast Cancer Debu Tripathy
15:30:00 PARP and Its Inhibition in Breast Cancer
16:00:00 Panel Discussion
16:20:00 Break
16:25:00 New Technology in Cancer Diagnosis and Treatment Jeffrey M. Trent
16:35:00 siRNA Applications Spyro Mousses
16:50:00 Application of New Molecular Tools for Personalized Therapy John D Carpten
17:05:00 Clonal Analysis of Tumors Michael T. Barrett
17:20:00 Question-and-Answer Session
17:40:00 Adjourn
19:00:00 Reception
Friday, February 12, 2010
07:30:00 Continental Breakfast
07:35:00 Biomarker Panel Glen J. Weiss
08:00:00 Presession Survey
08:10:00 Angiogenesis Biomarkers: One Year Later, Have We Made Progress? Robert S. Kerbel
08:40:00 Adjuvant Therapy With Angiogenesis Inhibitors: Lessons From Clinical Trials
09:10:00 Predictive Biomarkers for Cancer Therapy Robert B. Diasio
09:30:00 Biomarkers to Predict Toxicity: Are They Useful?
09:50:00 Functional Imaging Ronald Korn
10:10:00 Panel Discussion
10:30:00 Break
10:35:00 Cancer of Unknown Primary Origin and Gynecologic Cancer Ramesh K. Ramanathan
10:45:00 New Assays and a Case Study for CUP
11:15:00 A Personalized Therapy Approach to Ovarian Cancer
11:45:00 Panel Discussion
12:05:00 Lunch
12:30:00 Didactic and Case-Based Discussions: Novel Pathways and Targets Glen J. Weiss
13:05:00 Presession Survey
13:15:00 Targeting the EML4-ALK Fusion Protein in NSCLC Alexander A. Adjei
13:45:00 Targeting the Notch Signaling Pathway Anthony Tolcher
14:15:00 Vaccines in Cancer
14:45:00 Targeting the PI3K-mTOR-Akt Pathway Patricia LoRusso
15:15:00 Panel Discussion
15:35:00 Break
15:40:00 Practical Considerations in Molecular Oncology Ramesh K. Ramanathan
15:50:00 Supportive Care: A Molecular Approach to Treating Fatigue and Pain Gayle Jameson
16:20:00 The Sixth Vital Sign and What It Means to the Practicing Oncologist Daniel Von Hoff
16:50:00 Panel Discussion
17:10:00 Adjourn
Saturday, February 13, 2010
07:30:00 Continental Breakfast
07:35:00 Didactic and Case-Based Discussions: Targeting Cellular Processes Raoul Tibes
08:00:00 Presession Survey
08:10:00 Inducing Tumor Cell Death by Regulating Apoptosis Daruka Mahadevan
08:40:00 Targeting the Tumor Cell Cycle Mitesh Borad
09:10:00 Panel Discussion
09:30:00 Case Studies: Genomics and Personalized Medicine for Difficult Cancers Tara Iyengar
09:30:00 Break
09:45:00 Gastrointestinal Stromal Tumors
10:15:00 Pancreatic Cancer Ramesh K. Ramanathan
10:45:00 Primary and Metastatic Brain Tumors
11:15:00 Endocrine and Rare Tumors Michael J. Demeure
11:45:00 Rare Tumors: A Personalized Therapy Approach With a Case History Razelle Kurzrock
12:15:00 Panel Discussion
12:35:00 Closing Remarks Ramesh K. Ramanathan
12:40:00 Adjourn
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.